4-161459235-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_020116.5(FSTL5):c.1693G>A(p.Glu565Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020116.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSTL5 | NM_020116.5 | c.1693G>A | p.Glu565Lys | missense_variant | Exon 14 of 16 | ENST00000306100.10 | NP_064501.2 | |
FSTL5 | NM_001128427.3 | c.1690G>A | p.Glu564Lys | missense_variant | Exon 14 of 16 | NP_001121899.1 | ||
FSTL5 | NM_001128428.3 | c.1663G>A | p.Glu555Lys | missense_variant | Exon 13 of 15 | NP_001121900.1 | ||
FSTL5 | XM_011532126.1 | c.1666G>A | p.Glu556Lys | missense_variant | Exon 13 of 15 | XP_011530428.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSTL5 | ENST00000306100.10 | c.1693G>A | p.Glu565Lys | missense_variant | Exon 14 of 16 | 1 | NM_020116.5 | ENSP00000305334.4 | ||
FSTL5 | ENST00000379164.8 | c.1690G>A | p.Glu564Lys | missense_variant | Exon 14 of 16 | 1 | ENSP00000368462.4 | |||
FSTL5 | ENST00000427802.2 | c.1663G>A | p.Glu555Lys | missense_variant | Exon 13 of 15 | 1 | ENSP00000389270.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457446Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 725320
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1693G>A (p.E565K) alteration is located in exon 14 (coding exon 13) of the FSTL5 gene. This alteration results from a G to A substitution at nucleotide position 1693, causing the glutamic acid (E) at amino acid position 565 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.